With COVID-19 cases continuing to rise in the United States, many companies have come forward to strengthen the testing capabilities in the nation. Rite Aid Corporation, one of the leading American companies delivering healthcare services and retail products, has reportedly expanded COVID-19 testing sites to seven new locations in New Jersey, Michigan, Ohio, and New York.
Sources cite that Rite Aid partnered with U.S. HHS (Department of Health and Human Services) to conduct testing at Flint, Lansing, Detroit, South N.J, Cleveland, Utica, and Toledo. The company will conduct testing between 9 a.m. – 5 p. m. every day and expects to carry out around 200 tests through online appointments.
As per reports, all these testing sites will use self-swab nasal tests directed by Rite Aid pharmacists. The company’s testing procedure is in line with CDC (Centers for Disease Control and Prevention) guidelines.
Rite Aid will conduct testing at zero cost for eligible individuals who meet CDC criteria. Participants must provide government identity proof and pre-register online at www.riteaid.com to book a slot for testing. Moreover, a participant must be at least 18 years old to become eligible for testing.
In collaboration with HHS, it is likely that the company may conduct an additional drive-up for COVID-19 testing in the days to come, at Rite Aid’s stores in Michigan, New Jersey, New York, Ohio, Idaho, Pennsylvania, Delaware, and Virginia.
According to sources, Rite Aid has collaborated with Verily and will implement its baseline COVID-19 Program to provide scheduling, screening, and outcomes to participants. The company also selected BioReference Laboratories to arrange COVID-19 laboratory testing for all drive-up locations.
Also, PWNHealth, a national clinician network that facilitates easy and safe access to diagnostic testing, has provided clinical oversight for this testing program. The company will provide a continuous update on its progress with COVID-19 testing.